Lung Transplantation for Cystic Lung Diseases: Lymphangioleiomyomatosis, Histiocytosis X, and Sarcoidosis
The DOI matches its Crossref record.
Abstract
Lung transplantation for respiratory failure due to lymphangioleiomyomatosis, histiocytosis X, and sarcoidosis is a therapeutic option in selected patients. These indications account for less than 6% of all lung transplant procedures, and experience is relatively scarce. Pulmonary function testing at evaluation usually shows an obstructive pattern in lymphangioleiomyomatosis, whereas histiocytosis presents with a mixed pattern, and sarcoidosis with a restrictive pattern. Lung diffusion capacity is similarly reduced, however, only histiocytosis and sarcoidosis are often associated with pulmonary hypertension. In all three diseases extrapulmonary manifestations, although of different kinds, are common and must be investigated before transplantation to avoid posttransplant diagnostic pitfalls. In all these diseases, single and bilateral transplantation show comparable results. Typical complications in lymphangioleiomyomatosis include intraoperative severe intrathoracic bleeding, posttransplant chylothorax, pneumothorax, and bleeding of angiomyolipomas. In histiocytosis, extrapulmonary manifestations in bones and pituitary gland may progress. These diseases typically recur in the allograft, leading to clinical symptoms in histiocytosis whereas recurrence in lymphangioleiomyomatosis and sarcoidosis is most often asymptomatic. Survival is similar to patients transplanted for other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis
Johnson, S. R., Cordier, J. F., Lazor, R., Cottin, V., Costabel, U., Harari, S., Reynaud-Gaubert, M., Boehler, A., Brauner, M., Popper, H., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00076209 · Cited by 590
Self-citationAdult pulmonary Langerhans’ cell histiocytosis
Tazi, A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00024004 · Cited by 311
The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis
Kpodonu, J., Massad, M. G., Chaer, R. A., Caines, A., Evans, A., Snow, N. J., & Geha, A. S. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.09.013 · Cited by 106
Lung transplantation for lymphangioleiomyomatosis: the European experience
Benden, C., Rea, F., Behr, J., Corris, P. A., Reynaud-Gaubert, M., Stern, M., Speich, R., & Boehler, A. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.09.014 · Cited by 99
Self-citationLung transplantation for lymphangioleiomyomatosis: the French experience
Reynaud-Gaubert, M., Mornex, J.-F., Mal, H., Treilhaud, M., Dromer, C., Quétant, S., Leroy-Ladurie, F., Guillemain, R., Philit, F., Dauriat, G., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e31817c15df · Cited by 87
Metadata
- Authors
- Boehler, A.
- Venue
- Seminars in Respiratory and Critical Care Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001
- Volume
- 22
- Issue
- 05
- Pages
- 509-516
- ISSN
- 1069-3424 (ISSN-L)
- 1098-9048
- OpenAlex
- W2006552330
- Cited by
- 23
- References
- 0
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lung Transplantation for Cystic Lung Diseases: Lymphangioleiomyomatosis, Histiocytosis X, and Sarcoidosis. https://app.cochat.ai/papers/10.1055/s-2001-18423
- The paper
- Boehler, A. (2001). Lung Transplantation for Cystic Lung Diseases: Lymphangioleiomyomatosis, Histiocytosis X, and Sarcoidosis. Seminars in Respiratory and Critical Care Medicine. https://doi.org/10.1055/s-2001-18423
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.